Skip to content

NEUROMETRIX, INC.: 10-Q filed 2020-10-22

What NEUROMETRIX, INC. reported in its quarterly report filed 2020-10-22 (fiscal Q3 2020): 37 published measures, 106 facts as tagged in accession 0001628280-20-014684.

This filing

Form
10-Q (quarterly report)
Filed
2020-10-22
Fiscal period
fiscal Q3 2020
Accession
0001628280-20-014684 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEUROMETRIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-308,340,038USD
At 2019-12-316,893,686USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-302,968,266USD
At 2019-12-314,363,452USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-305,371,772USD
At 2020-06-305,488,616USD
At 2020-03-312,514,118USD
At 2019-12-312,530,234USD
At 2019-09-303,573,510USD
At 2019-06-304,857,650USD
At 2019-03-318,192,411USD
At 2018-12-316,097,811USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-304,929,175USD
At 2019-12-313,126,206USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-257,113USD92
2020-01-01 to 2020-09-30-1,766,428USD274
2020-04-01 to 2020-06-30-851,944USD91
2020-01-01 to 2020-03-31-657,371USD91
2019-07-01 to 2019-09-30-1,404,600USD92
2019-01-01 to 2019-09-30-2,716,284USD273
2019-04-01 to 2019-06-30-3,362,191USD91
2019-01-01 to 2019-03-312,050,507USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-2,348,068USD274
2019-01-01 to 2019-09-30-3,560,113USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-09-300USD274
2019-01-01 to 2019-09-3041,177USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-304,151,037USD274
2019-01-01 to 2019-09-307,497USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-300USD274
2019-01-01 to 2019-09-30-41,177USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-196,556,033USD
At 2019-12-31-194,789,605USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,784,657shares92
2020-01-01 to 2020-09-302,755,903shares274
2019-07-01 to 2019-09-30978,175shares92
2019-01-01 to 2019-09-30886,609shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,784,657shares92
2020-01-01 to 2020-09-302,755,903shares274
2019-07-01 to 2019-09-30978,175shares92
2019-01-01 to 2019-09-30886,609shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-30205,676USD
At 2019-12-31273,448USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-30413,178USD274
2019-01-01 to 2019-09-30184,486USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-257,887USD92
2020-01-01 to 2020-09-30-1,768,751USD274
2019-07-01 to 2019-09-30-1,412,064USD92
2019-01-01 to 2019-09-30-9,875,748USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-307,290,140USD
At 2019-12-315,430,814USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-302,386,363USD
At 2019-12-313,446,778USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30192,356USD
At 2019-12-31725,658USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-30633,146USD
At 2019-12-31298,967USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,756,501USD92
2020-01-01 to 2020-09-305,684,104USD274
2019-07-01 to 2019-09-302,585,743USD92
2019-01-01 to 2019-09-3011,059,027USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-301,050,293USD
At 2019-12-311,163,714USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,498,614USD92
2020-01-01 to 2020-09-303,915,353USD274
2019-07-01 to 2019-09-301,173,679USD92
2019-01-01 to 2019-09-301,183,279USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-07-01 to 2020-09-30537,614USD92
2020-01-01 to 2020-09-301,652,890USD274
2019-07-01 to 2019-09-30914,322USD92
2019-01-01 to 2019-09-306,382,340USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-30652,671USD92
2020-01-01 to 2020-09-301,846,569USD274
2019-07-01 to 2019-09-30475,137USD92
2019-01-01 to 2019-09-302,365,139USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-303,784,657shares
At 2019-12-311,400,674shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-09-304,929,175USD
At 2019-12-313,126,206USD
At 2019-09-303,186,636USD
At 2018-12-316,780,429USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-30201,927,426USD
At 2019-12-31197,319,698USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-30815,558USD
At 2019-12-311,159,774USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-301,011,228USD
At 2019-12-311,443,574USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-30677,526USD
At 2019-12-31652,919USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-1,766,428USD274
2019-01-01 to 2019-09-30-2,716,284USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30762,903USD92
2020-01-01 to 2020-09-302,693,146USD274
2019-07-01 to 2019-09-301,462,887USD92
2019-01-01 to 2019-09-304,646,932USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-01-01 to 2020-09-3067,772USD274
2019-01-01 to 2019-09-3098,166USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30774USD92
2020-01-01 to 2020-09-302,323USD274
2019-07-01 to 2019-09-307,464USD92
2019-01-01 to 2019-09-307,159,464USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30334,179USD274
2019-01-01 to 2019-09-30-558,968USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-113,421USD274
2019-01-01 to 2019-09-30357,673USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-533,302USD274
2019-01-01 to 2019-09-30-659,538USD273

Inspect the source

Entity
NEUROMETRIX, INC. / CIK 0001289850
Captured
2026-09-21T17:18:17.667Z
SEC response SHA-256
a8bcb6176e39f2b78532ab77047334a9ea544316148327f0e4d18bc7ac5fd7fa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001289850.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))